Immediate Impact
74 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Tryptophan metabolism in health and disease
2023 Standout
Works of R Benning being referenced
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
1996
Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors
1993
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| R Benning | 413 | 28 | 28 | 339 | 334 | 8 | 426 | |
| Jeremiah V. Ojeaburu | 404 | 41 | 39 | 310 | 296 | 7 | 422 | |
| L Piscitelli | 377 | 15 | 53 | 337 | 246 | 12 | 428 | |
| Jerome Zacks | 442 | 27 | 36 | 378 | 351 | 14 | 510 | |
| S. Nasoni | 349 | 19 | 20 | 321 | 221 | 8 | 373 | |
| L. Somma | 252 | 21 | 38 | 359 | 202 | 10 | 403 | |
| Showkat Bashir | 394 | 42 | 49 | 308 | 286 | 15 | 436 | |
| C A Stewart | 348 | 46 | 55 | 262 | 303 | 8 | 492 | |
| Jeffrey A. Norton | 351 | 53 | 122 | 263 | 218 | 10 | 465 | |
| Philippa Davies | 347 | 9 | 22 | 312 | 262 | 7 | 385 | |
| Esther I. van Vliet | 364 | 34 | 13 | 322 | 262 | 9 | 474 |
All Works
Loading papers...